The analysis of the frequency of combinations of the AGO1 rs636832 and GEMIN4 rs7813 genotypes suggests that the heterozygotes of these SNPs appear to cooperate in reducing the risk of developing MS. This evidence concerns the gene AGO1 and myeloid sarcoma.